Skip to main content
. Author manuscript; available in PMC: 2006 Sep 13.
Published in final edited form as: Oncogene. 2006 Mar 13;25(11):1649–1658. doi: 10.1038/sj.onc.1209374

Table 1.

Common human NAT2 alleles (haplotypes)

Allele (haplotype)a Nucleotide Change(s)b Amino Acid Change(s)c Catalytic activityd
NAT2*4 None None High
NAT2*5A 341T>C; 481C>T I114T Low
NAT2*5B 341T>C; 481C>T; 803A>G I114T; K268R Low
NAT2*5C 341T>C; 803A>G I114T; K268R Low
NAT2*6A 282C>T ; 590G>A R197Q Low
NAT2*6B 590G>A R197Q Low
NAT2*7A 857G>A G286E Low
NAT2*7B 282C>T; 857G>A G286E Low
NAT2*12A 803A>G K268R High
NAT2*12B 282C>T; 803A>G K268R High
NAT2*12C 481C>T; 803A>G K268R High
NAT2*13 282C>T None High
NAT2*14A 191G>A R64Q Low
NAT2*14B 191G>A; 282C>T R64Q Low
a

Common NAT2 alleles (haplotypes) associated with low catalytic activityd and slow acetylator phenotype are bolded. Individuals homozygous for these alleles are slow acetylators.

b

Signature SNP for each allele cluster is bolded.

c

Amino acid substitutions that confer reduced NAT2 activities are underlined.